144 related articles for article (PubMed ID: 2683072)
1. Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts.
Richman A; Hayday A
Science; 1989 Oct; 246(4929):494-7. PubMed ID: 2683072
[TBL] [Abstract][Full Text] [Related]
2. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
Rabbitts TH; Forster A; Hamlyn P; Baer R
Nature; 1984 Jun 14-20; 309(5969):592-7. PubMed ID: 6547209
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
[TBL] [Abstract][Full Text] [Related]
5. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
Spencer CA; LeStrange RC; Novak U; Hayward WS; Groudine M
Genes Dev; 1990 Jan; 4(1):75-88. PubMed ID: 2307371
[TBL] [Abstract][Full Text] [Related]
6. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the normal mouse c-myc oncogene in human lymphoma cells.
Feo S; ar-Rushdi A; Huebner K; Finan J; Nowell PC; Clarkson B; Croce CM
Nature; 1985 Feb 7-13; 313(6002):493-5. PubMed ID: 3838203
[TBL] [Abstract][Full Text] [Related]
8. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.
Croce CM; Erikson J; ar-Rushdi A; Aden D; Nishikura K
Proc Natl Acad Sci U S A; 1984 May; 81(10):3170-4. PubMed ID: 6328505
[TBL] [Abstract][Full Text] [Related]
9. Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation.
Szajnert MF; Saule S; Bornkamm GW; Wajcman H; Lenoir GM; Kaplan JC
Nucleic Acids Res; 1987 Jun; 15(11):4553-65. PubMed ID: 3035497
[TBL] [Abstract][Full Text] [Related]
10. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
11. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
13. A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein.
Zajac-Kaye M; Gelmann EP; Levens D
Science; 1988 Jun; 240(4860):1776-80. PubMed ID: 2454510
[TBL] [Abstract][Full Text] [Related]
14. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
Mathieu-Mahul D; Bernheim A; Berger R; Mauchauffe M; Flandrin G; Larsen CJ
Nouv Rev Fr Hematol (1978); 1985; 27(3):157-61. PubMed ID: 2993997
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.
Ji L; Arcinas M; Boxer LM
Mol Cell Biol; 1994 Dec; 14(12):7967-74. PubMed ID: 7969136
[TBL] [Abstract][Full Text] [Related]
16. Structure and activity of the translocated c-myc in mouse plasmacytoma XRPC-24.
Moav B; Horowitz M; Cohen JB; Rechavi G; Eliyahu E; Oren M; Givol D
Gene; 1986; 48(2-3):297-300. PubMed ID: 3549466
[TBL] [Abstract][Full Text] [Related]
17. Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.
Eick D; Bornkamm GW
EMBO J; 1989 Jul; 8(7):1965-72. PubMed ID: 2551669
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma.
Erikson J; ar-Rushdi A; Drwinga HL; Nowell PC; Croce CM
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):820-4. PubMed ID: 6402776
[TBL] [Abstract][Full Text] [Related]
19. A translocated human c-myc oncogene is altered in a conserved coding sequence.
Murphy W; Sarid J; Taub R; Vasicek T; Battey J; Lenoir G; Leder P
Proc Natl Acad Sci U S A; 1986 May; 83(9):2939-43. PubMed ID: 3517879
[TBL] [Abstract][Full Text] [Related]
20. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
